platinum в таблице с результатами
This commit is contained in:
16
report.tex
16
report.tex
@@ -244,7 +244,21 @@
|
|||||||
\hline
|
\hline
|
||||||
\end{tabularx}
|
\end{tabularx}
|
||||||
\end{table}
|
\end{table}
|
||||||
|
|
||||||
|
\addtocounter{table}{-1}
|
||||||
|
\begin{table}[h!]
|
||||||
|
\centering
|
||||||
|
\caption{Results obtained in research papers (continued).}
|
||||||
|
\footnotesize
|
||||||
|
\begin{tabularx}{\textwidth}{|X|X|X|X|}
|
||||||
|
\hline
|
||||||
|
\textbf{Article} & \textbf{Key results} & \textbf{Best algorithms} & \textbf{Metrics} \\
|
||||||
|
\hline
|
||||||
|
A Predictive Model for Initial Platinum-Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue-Derived Small Extracellular Vesicles~\cite{platinum} & Found that three immune-related proteins—CCR1, IGHV3-35, and CD72—along with the presence of postoperative residual tumors, are strong predictors of platinum resistance in EOC patients. Proposed a model that can predict the efficacy of initial platinum-based chemotherapy. & Least absolute shrinkage and selection operator (LASSO) regression and linear regression (LR) & Area under curve (AUC) of 0.864 \\
|
||||||
|
\hline
|
||||||
|
\end{tabularx}
|
||||||
|
\end{table}
|
||||||
|
|
||||||
% \section*{Conclusion}
|
% \section*{Conclusion}
|
||||||
% \addcontentsline{toc}{section}{Conclusion}
|
% \addcontentsline{toc}{section}{Conclusion}
|
||||||
% Conclusion text
|
% Conclusion text
|
||||||
|
|||||||
Reference in New Issue
Block a user